Literature DB >> 24936242

3-Hydroxyquinolin-2(1H)-ones As Inhibitors of Influenza A Endonuclease.

Hye Yeon Sagong1, Ajit Parhi1, Joseph D Bauman2, Disha Patel1, R S K Vijayan2, Kalyan Das2, Eddy Arnold2, Edmond J LaVoie1.   

Abstract

Several 3-hydroxyquinolin-2(1H)-ones derivatives were synthesized and evaluated as inhibitors of 2009 pandemic H1N1 influenza A endonuclease. All five of the monobrominated 3-hydroxyquinolin(1H)-2-ones derivatives were synthesized. Suzuki-coupling of p-fluorophenylboronic acid with each of these brominated derivatives provided the respective p-fluorophenyl 3-hydroxyquinolin(1H)-2-ones. In addition to 3-hydroxyquinolin-2(1H)-one, its 4-methyl, 4-phenyl, 4-methyl-7-(p-fluorophenyl), and 4-phenyl-7-(p-fluorophenyl) derivatives were also synthesized. Comparative studies on their relative activity revealed that both 6- and 7-(p-fluorophenyl)-3-hydroxyquinolin-2(1H)-one are among the more potent inhibitors of H1N1 influenza A endonuclease. An X-ray crystal structure of 7-(p-fluorophenyl)-3-hydroxyquinolin-2(1H)-one complexed to the influenza endonuclease revealed that this molecule chelates to two metal ions at the active site of the enzyme.

Entities:  

Keywords:  3-hydroxyquinolin-2-ones; antiviral; endonuclease; influenza A; quinolinones

Year:  2013        PMID: 24936242      PMCID: PMC4056971          DOI: 10.1021/ml4001112

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  20 in total

1.  Oseltamivir resistance--disabling our influenza defenses.

Authors:  Anne Moscona
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

2.  Permissive secondary mutations enable the evolution of influenza oseltamivir resistance.

Authors:  Jesse D Bloom; Lizhi Ian Gong; David Baltimore
Journal:  Science       Date:  2010-06-04       Impact factor: 47.728

Review 3.  Structures of influenza A proteins and insights into antiviral drug targets.

Authors:  Kalyan Das; James M Aramini; Li-Chung Ma; Robert M Krug; Eddy Arnold
Journal:  Nat Struct Mol Biol       Date:  2010-04-11       Impact factor: 15.369

4.  Development of a series of 3-hydroxyquinolin-2(1H)-ones as selective inhibitors of HIV-1 reverse transcriptase associated RNase H activity.

Authors:  Virginie Suchaud; Fabrice Bailly; Cédric Lion; Enzo Tramontano; Francesca Esposito; Angela Corona; Frauke Christ; Zeger Debyser; Philippe Cotelle
Journal:  Bioorg Med Chem Lett       Date:  2012-04-30       Impact factor: 2.823

5.  Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds.

Authors:  J Tomassini; H Selnick; M E Davies; M E Armstrong; J Baldwin; M Bourgeois; J Hastings; D Hazuda; J Lewis; W McClements
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

6.  A concise and versatile synthesis of viridicatin alkaloids from cyanoacetanilides.

Authors:  Yusuke Kobayashi; Takashi Harayama
Journal:  Org Lett       Date:  2009-04-02       Impact factor: 6.005

7.  The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit.

Authors:  Alexandre Dias; Denis Bouvier; Thibaut Crépin; Andrew A McCarthy; Darren J Hart; Florence Baudin; Stephen Cusack; Rob W H Ruigrok
Journal:  Nature       Date:  2009-02-04       Impact factor: 49.962

8.  Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site.

Authors:  Puwei Yuan; Mark Bartlam; Zhiyong Lou; Shoudeng Chen; Jie Zhou; Xiaojing He; Zongyang Lv; Ruowen Ge; Xuemei Li; Tao Deng; Ervin Fodor; Zihe Rao; Yingfang Liu
Journal:  Nature       Date:  2009-02-04       Impact factor: 49.962

9.  Structural and biochemical basis for development of influenza virus inhibitors targeting the PA endonuclease.

Authors:  Rebecca M DuBois; P Jake Slavish; Brandi M Baughman; Mi-Kyung Yun; Ju Bao; Richard J Webby; Thomas R Webb; Stephen W White
Journal:  PLoS Pathog       Date:  2012-08-02       Impact factor: 6.823

10.  Structural analysis of specific metal chelating inhibitor binding to the endonuclease domain of influenza pH1N1 (2009) polymerase.

Authors:  Eva Kowalinski; Chloe Zubieta; Andrea Wolkerstorfer; Oliver H J Szolar; Rob W H Ruigrok; Stephen Cusack
Journal:  PLoS Pathog       Date:  2012-08-02       Impact factor: 6.823

View more
  17 in total

Review 1.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

2.  Mutational analysis of the binding pockets of the diketo acid inhibitor L-742,001 in the influenza virus PA endonuclease.

Authors:  Annelies Stevaert; Roberto Dallocchio; Alessandro Dessì; Nicolino Pala; Dominga Rogolino; Mario Sechi; Lieve Naesens
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

3.  Aryl and Arylalkyl Substituted 3-Hydroxypyridin-2(1H)-ones: Synthesis and Evaluation as Inhibitors of Influenza A Endonuclease.

Authors:  Hye Yeon Sagong; Joseph D Bauman; Aitor Nogales; Luis Martínez-Sobrido; Eddy Arnold; Edmond J LaVoie
Journal:  ChemMedChem       Date:  2019-05-14       Impact factor: 3.466

4.  Identification and characterization of influenza variants resistant to a viral endonuclease inhibitor.

Authors:  Min-Suk Song; Gyanendra Kumar; William R Shadrick; Wei Zhou; Trushar Jeevan; Zhenmei Li; P Jake Slavish; Thomas P Fabrizio; Sun-Woo Yoon; Thomas R Webb; Richard J Webby; Stephen W White
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-14       Impact factor: 11.205

5.  Computation-guided discovery of influenza endonuclease inhibitors.

Authors:  Eric Chen; Robert V Swift; Nazilla Alderson; Victoria A Feher; Gen-Sheng Feng; Rommie E Amaro
Journal:  ACS Med Chem Lett       Date:  2014-01-09       Impact factor: 4.345

6.  Crystallographic fragment screening and structure-based optimization yields a new class of influenza endonuclease inhibitors.

Authors:  Joseph D Bauman; Disha Patel; Steven F Baker; R S K Vijayan; Amy Xiang; Ajit K Parhi; Luis Martínez-Sobrido; Edmond J LaVoie; Kalyan Das; Eddy Arnold
Journal:  ACS Chem Biol       Date:  2013-09-13       Impact factor: 5.100

7.  A Novel Endonuclease Inhibitor Exhibits Broad-Spectrum Anti-Influenza Virus Activity In Vitro.

Authors:  Jeremy C Jones; Bindumadhav M Marathe; Christian Lerner; Lukas Kreis; Rodolfo Gasser; Philippe Noriel Q Pascua; Isabel Najera; Elena A Govorkova
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

8.  Investigation of the salicylaldehyde thiosemicarbazone scaffold for inhibition of influenza virus PA endonuclease.

Authors:  Dominga Rogolino; Alessia Bacchi; Laura De Luca; Gabriele Rispoli; Mario Sechi; Annelies Stevaert; Lieve Naesens; Mauro Carcelli
Journal:  J Biol Inorg Chem       Date:  2015-09-01       Impact factor: 3.862

9.  Phenyl substituted 4-hydroxypyridazin-3(2H)-ones and 5-hydroxypyrimidin-4(3H)-ones: inhibitors of influenza A endonuclease.

Authors:  Hye Yeon Sagong; Joseph D Bauman; Disha Patel; Kalyan Das; Eddy Arnold; Edmond J LaVoie
Journal:  J Med Chem       Date:  2014-09-29       Impact factor: 7.446

10.  A novel small-molecule inhibitor of influenza A virus acts by suppressing PA endonuclease activity of the viral polymerase.

Authors:  Shuofeng Yuan; Hin Chu; Kailash Singh; Hanjun Zhao; Ke Zhang; Richard Y T Kao; Billy K C Chow; Jie Zhou; Bo-Jian Zheng
Journal:  Sci Rep       Date:  2016-03-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.